A deeper understanding of microbial-disease pathways could lead to more targeted treatments, the researchers wrote in their study, published today (June 24) in the journal Science Translational Medicine
As the public may recall, Hims & Hers began selling various Eli Lilly drugs on their platform last monthboth branded forms of tirzepatideincluding Zepbound, a GLP-1 receptor agonist approved by the FDA for weight loss, and Mounjaro, which is not approved for weight loss but for the treatment of type 2 diabetes
Orforglipron has no cardiovascular outcomes data
It eliminates the risk of interactions or side effects from additives and is often less expensive
doi: 10.1016/j.ctim.2020.102398 Summary Keywords circadian rhythm, gut microbial dynamics, gut microbiota, liver axis, metabolic related fatty liver disease Citation Chen Y-J, Yang B-W, Gu Z-C and Han J (2026) Interplay between circadian rhythms, gut microbiota, and MASLD: from mechanistic foundations to therapeutic opportunities
